Skip to content
Clinical Trial Events
Follow

Clinical Trials on Alzheimer's Disease (CTAD) · 2026

19th Clinical Trials on Alzheimer's Disease (CTAD) 2026

Nov 16–19

Nov 16–19, 2026

Boston Marriott Copley Place · Boston, MA · In person and online

CTAD is an Alzheimer's disease clinical research conference established in 2008, designed by and for AD researchers to discuss clinical research and build international collaboration. The 19th edition (CTAD26) takes place in Boston with in-person and remote virtual attendance.

Venue
Boston Marriott Copley Place
Program
42 sessions
64 speakers

Agenda

Times in Boston (EST)
Mon, Nov 16 Tue, Nov 17 Wed, Nov 18 Thu, Nov 19

  1. 2:15 PM

    60 min

    Poster · Gloucester & Atrium - 3rd floor

    Poster Walking Tour

  2. 3:15 PM

    10 min

    Other

    Welcome Ceremony & CTAD Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research

    Reisa Sperling, Brigham and Women's Hospital, Harvard Medical School Paul Aisen, Alzheimer's Therapeutic Research Institute, University of Southern California Sandrine Andrieu, Toulouse University Hospital and INSERM 1295 Rachelle Doody Lefkos Middleton, Imperial College London Jacques Touchon, Montpellier University Bruno Vellas, IHU HealthAge, Toulouse University Michael Weiner, University of California, San Francisco (UCSF) Jeffrey Cummings, University of Nevada Las Vegas (UNLV)

  3. 3:25 PM

    25 min

    Keynote · Ballroom - 4th floor

    Keynote 1: New Molecules in Phase 2b – Proof of Concept and Beyond

    Jeffrey Cummings, University of Nevada Las Vegas (UNLV) Bruno Vellas, IHU HealthAge, Toulouse University

  4. 3:50 PM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Sharon Sha, Stanford University Chris Chen, Dementia Research Centre (Singapore)

  5. 4:50 PM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 1: Visualizing the Brainshuttle™: Pioneering neuroimaging and mechanistic insights of amyloid clearance with trontinemab

    Tammie L.S. Benzinger, Washington University in St. Louis Luka Kulic, F. Hoffmann-La Roche Ltd Gregory Klein, F. Hoffmann-La Roche Ltd Elsmarieke Van De Giessen, Amsterdam UMC, Vrije Universiteit

  6. 5:30 PM

    45 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Eric McDade, Washington University in St. Louis Jacques Touchon, Montpellier University

  7. 6:15 PM

    60 min

    Networking · Ballroom Foyer - 4th floor

    CTAD Welcome Reception

  1. 7:30 AM

    60 min

    Poster · Gloucester & Atrium - 3rd floor

    Poster Walking Tour

  2. 8:30 AM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 2: When Target Engagement Is Not Enough: Lessons from Posdinemab on Bridging Tau Biology to Clinical Outcomes

    Fiona Elwood, Johnson & Johnson Ziad S. Saad, Johnson & Johnson Gallen Triana-Baltzer, Johnson & Johnson Gil D. Rabinovici, University of California, San Francisco (UCSF)

  3. 9:10 AM

    25 min

    Keynote · Ballroom - 4th floor

    Keynote 2: A Glimpse of the Future: How Diagnostics, Therapies, Trials, and Concepts of Prevention Must Evolve

    Geoffrey A. Kerchner, F. Hoffmann-La Roche Ltd Reisa Sperling, Brigham and Women's Hospital, Harvard Medical School

  4. 9:35 AM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Lon Schneider, USC Keck School of Medicine Sandrine Andrieu, Toulouse University Hospital and INSERM 1295

  5. 10:35 AM

    30 min

    Break · Gloucester & Atrium - 3rd floor

    Coffee Break — Poster Session and Rising Star Showcase

    Connor Dietz, University of British Columbia Zahra Shirzadi, Massachusetts General Hospital, Harvard Medical School

  6. 11:05 AM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 3: Remote Digital Biomarkers in Alzheimer's Disease Clinical Trials: From Scalable Prescreening to Sensitive AI-Enabled Assessment

    Gustavo A. Jimenez-Maggiora, Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC Duygu Tosun, University of California, San Francisco (UCSF) Rachel L. Nosheny, University of California, San Francisco (UCSF) Kathryn V. Papp, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital and Massachusetts General Hospital; Harvard Medical School Emil Fristed, Novoic Ltd.

  7. 11:45 AM

    35 min

    Panel · Ballroom - 4th floor

    Biotech Showcase: Fueling Innovation: The Vital Role of Biotech in Alzheimer's Research

    Laura Nisenbaum, Alzheimer's Drug Discovery Foundation (ADDF) Michael Weiner, University of California, San Francisco (UCSF) David Dolby, Dolby Family Ventures

  8. 12:20 PM

    75 min

    Break · Gloucester & Atrium - 3rd floor

    Lunch and Poster Sessions

  9. 1:35 PM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Susan Landau, Helen Wills Neuroscience Institute, University of California, Berkeley Lefkos Middleton, Imperial College London

  10. 2:35 PM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 4: Neuroinflammation in Alzheimer's Disease: Targeting the NLRP3 Inflammasome and Neuroimmune Crosstalk

    Malu Tansey, Indiana University School of Medicine Róisín M. McManus, German Center for Neurodegenerative Diseases (DZNE) Gennaro Pagano, F. Hoffmann-La Roche Ltd

  11. 3:15 PM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Rachelle Doody Pascal Geldsetzer, Stanford University

  12. 4:15 PM

    30 min

    Break · Gloucester & Atrium - 3rd floor

    Coffee Break — Poster Session and Rising Star Showcase

    Yuta Katsumin, Massachusetts General Hospital, Harvard Medical School Dorothy MacFarlane, Adams Clinical

  13. 4:45 PM

    40 min

    Talk · Ballroom - 4th floor

    Late Breaking Symposium 1

  1. 7:30 AM

    60 min

    Poster · Gloucester & Atrium - 3rd floor

    Poster Walking Tour

  2. 8:30 AM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Rema Raman, University of Southern California Jeffrey Cummings, University of Nevada Las Vegas (UNLV)

  3. 9:30 AM

    25 min

    Keynote · Ballroom - 4th floor

    Keynote 3: Integration of Fluid Imaging and other Multimodal Biomarkers towards Optimizing Disease Understanding and New Therapeutics

    Susan Landau, Helen Wills Neuroscience Institute, University of California, Berkeley Michael Weiner, University of California, San Francisco (UCSF)

  4. 9:55 AM

    30 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Reisa Sperling, Brigham and Women's Hospital, Harvard Medical School Michael Weiner, University of California, San Francisco (UCSF)

  5. 10:25 AM

    35 min

    Break · Gloucester & Atrium - 3rd floor

    Coffee Break — Poster Session and Rising Star Showcase

    Dhruv Kapadia, Stanford University Casey Vanderlip, University of California, Irvine

  6. 11:00 AM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 5: Lecanemab Three Years Post-Approval: A Comprehensive Multicenter, Real-World, Retrospective Study (LEADER) in Diverse US Clinical Settings

    Marwan Sabbagh, Barrow Neurological Institute Jose Soria, The Neuron Clinic Tinatin Chabrashvili, SUNY Upstate Medical University Brent Berry, Minneapolis Clinic of Neurology

  7. 11:40 AM

    45 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Karim Bennys, Montpellier University Hospital Laura Nisenbaum, Alzheimer's Drug Discovery Foundation (ADDF)

  8. 12:25 PM

    75 min

    Break · Gloucester & Atrium - 3rd floor

    Lunch and Poster Sessions

  9. 1:40 PM

    105 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Marissa Denkinger, Banner Sun Health Research Institute Frank Longo, Stanford University

  10. 3:25 PM

    35 min

    Break · Gloucester & Atrium - 3rd floor

    Coffee Break — Poster Session

  11. 4:00 PM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Ann Hartry, Eli Lilly and Company Mike Rafii, University of Southern California

  12. 5:00 PM

    20 min

    Talk · Ballroom - 4th floor

    Biotech Showcase (Late Breaking)

    Melissa Lee, Alzheimer's Drug Discovery Foundation Andrea Pfeifer, Global BHP Braintrust

  1. 7:30 AM

    60 min

    Poster · Gloucester & Atrium - 3rd floor

    Poster Walking Tour

  2. 8:30 AM

    40 min

    Talk · Ballroom - 4th floor

    Symposium 6: Lessons from The Life's end Benefits of cannaBidiol and tetrahydrocannabinol (LiBBY) Study: Efficacy, Implementation, and Future Therapeutic Development in Advanced Dementia

    Olga Brawman-Mintzer, Medical University of South Carolina and Ralph H. Johnson VA Health Care System Jacobo Mintzer, Medical University of South Carolina Brigid Reynolds, Georgetown University Paul Aisen, Alzheimer's Therapeutic Research Institute, University of Southern California

  3. 9:10 AM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Thomas Karikari, University of Pittsburgh Heather Snyder, Alzheimer's Association

  4. 10:10 AM

    30 min

    Break · Gloucester & Atrium - 3rd floor

    Coffee Break — Poster Session

  5. 10:40 AM

    25 min

    Keynote · Ballroom - 4th floor

    Keynote 4: Beyond Amyloid and Tau: Roles of Proteomics in Clinical Trials

    Allan Levey, Emory University Paul Aisen, Alzheimer's Therapeutic Research Institute, University of Southern California

  6. 11:05 AM

    60 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Lucia Crivelli, FLENI Renaud La Joie, University of California, San Francisco (UCSF)

  7. 12:05 PM

    60 min

    Break · Gloucester & Atrium - 3rd floor

    Lunch and Poster Sessions

  8. 1:05 PM

    90 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Miranda Orr, Washington University School of Medicine Gad Marshall, Brigham and Women's Hospital, Harvard Medical School

  9. 2:35 PM

    75 min

    Talk · Ballroom - 4th floor

    Oral Communications

    Doris Molina-Henry, USC Keck School of Medicine, ATRI Mike Donohue, USC Epstein Family Alzheimer's Therapeutic Research Institute

  10. 3:50 PM

    20 min

    Talk · Gloucester & Atrium - 3rd floor

    Biotech Showcase and Introductory Panel

Speakers

Plan your trip

Map of Boston Marriott Copley Place with nearby hotels and places Open in Google Maps(opens in a new tab)
Venue Where to stay Around the venue

The venue

Boston Marriott Copley Place

110 Huntington Ave

Boston, MA 02116, United States

Directions from where you are

Walk Transit Drive

Opens Google Maps

Flights

Into Boston Logan International Airport · about 4 mi from the venue

Opens Google Flights, starting from your location.

Sign in to save your home airport

From $475

Get tickets(opens in a new tab)